Work

Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors

Year: 2016

Type: article

Study design: Observational Study

Source: Annals of Surgical Oncology

DOI: 10.1245/s10434-016-5171-x

Authors: Vincenzo Villani, Krishnan K. Mahadevan, Matteo Ligorio, Carlos Fernández-del Castillo, David T. Ting, Francesco Sabbatino, Irene Zhang, Mark Vangel, Soldano Ferrone, Andrew L. Warshaw, Keith D. Lillemoe, Jennifer Wargo, Vikram Deshpande, Cristina R. Ferrone

Institutions: Harvard University, Massachusetts General Hospital, University of Salerno, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Therapy of pancreatic cancer with 212Pb-labeled B7-H3 specific Ab and LDE225

OpenAlex ID: W2332402108

FWCI: 3.27

Cites: 24

Cited by: 32

Related to: 10